Holen Sie sich die Stockscreener-App
46.44
5.09%
-2.49
Vorhandelsmarkt:
46.46
0.02
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$48.93
Offen:
$48.45
24-Stunden-Volumen:
1.03M
Relative Volume:
0.87
Marktkapitalisierung:
$2.50B
Einnahmen:
$238.11M
Nettoeinkommen (Verlust:
$-31.45M
KGV:
-73.32
EPS:
-0.6334
Netto-Cashflow:
$7.66M
1W Leistung:
-3.35%
1M Leistung:
+17.63%
6M Leistung:
+31.56%
1J Leistung:
+198.46%
1-Tages-Spanne:
$45.26
$49.18
1-Wochen-Bereich:
$45.26
$50.66
52-Wochen-Spanne:
$13.64
$50.66
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
46.44 | 2.63B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen director Amy Wendell sells $646k in shares - Investing.com
Axogen director Amy Wendell sells $646k in shares By Investing.com - Investing.com Canada
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP - MarketBeat
Kathy Johnson Weiler Sells 14,150 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen, Inc. SEC Filing (Aug 11, 2026) - Stock Titan
Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed? - simplywall.st
Axogen Raises Its Revenue Outlook to at Least $279 Million But Does It Deserve An Upgrade? - Smartkarma
Axogen stock hits 52-week high at 47.09 USD By Investing.com - Investing.com South Africa
Axogen stock hits 52-week high at 47.09 USD - Investing.com India
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen (AXGN) Climbs 3.86% to $48.22 as Medtech Momentum Builds Ahead of Key ResistanceDark Pool Volume - Vinanet
Axogen, Inc. (AXGN) options chain - Yahoo Finance Australia
Assenagon Asset Management S.A. Trims Stock Position in AxoGen, Inc. $AXGN - MarketBeat
MFG Wealth Management Inc. Takes $1.20 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Axogen, Inc. (AXGN) director completes 14,150-share stock sale under Rule 10b5-1 plan - Stock Titan
AxoGen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Axogen (AXGN) Falls 2.28% as Shares Retreat Toward $42 Support ZoneLow Volume Node - Vinanet
HC Wainwright Forecasts AxoGen's Q3 Earnings (NASDAQ:AXGN) - MarketBeat
HC Wainwright Predicts AxoGen's Q1 Earnings (NASDAQ:AXGN) - MarketBeat
Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - Kalkine
Axogen Inc. (AXGN) Rises 2.08% to $42.21 as Nerve Repair Momentum BuildsAAII Neutral - Vinanet
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report - simplywall.st
Trace Biosciences Raises Strategic Investment From Axogen - Pulse 2.0
Vanguard Capital Management (AXGN) discloses 4.99% Axogen Inc ownership on Schedule 13G/A - Stock Titan
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55 - Moomoo
Citizens raises AxoGen stock price target to $55 on strong growth - Investing.com UK
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Incyte (INCY) - The Globe and Mail
H.C. Wainwright raises AxoGen stock price target to $53 on guidance - Investing.com Canada
AxoGen Inc (AXGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Axogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AXGN Looks 168.4% Overvalued on GF Value™ - GuruFocus
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):